A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis

American Journal of Surgical Pathology

Volumn 24, Issue 9, 2000, Pages 1201-1208

  Lax, Sigurd F ^a,c   Kurman, Robert J ^a,d   Pizer, Ellen S ^a   Wu, Lee ^b   Ronnett, Brigitte M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Binary grading system; Endometrial carcinoma; Endometrioid carcinoma; FIGO grading system; Nuclear grading; Prognosis; Reproducibility

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MYOMETRIUM; NECROSIS; OBSERVER VARIATION; PREDICTION; PROGNOSIS; REPRODUCIBILITY; SOLID TUMOR; UTERUS CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; NEOPLASM STAGING; OBSERVER VARIATION; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 0033863946     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200009000-00002     Document Type: Article

References (18)

1. Announcements FIGO stages - 1988 revision
2. FIGO survival data
3. Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease
4. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma
5. Endometrial cancer in premenopausal women 45 years and younger
6. The prognostic value of semiquantitative nuclear grading in endometrial carcinomas
7. Endometrial carcinoma
8. Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups
9. Evaluation of the reproducibility of the revised 1988 International Federation of Gynecology and Obstetrics grading system of endometrial cancers with special emphasis on nuclear grading
10. Carcinoma of the endometrium: Do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications?
11. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic oncology group study no. 122
12. The prognosis in early endometrial carcinoma. The importance of uterine papillary serous carcinoma (UPSC), age, FIGO grade and nuclear grade
13. Morphological criteria for prognosis of endometrial carcinoma with special regard to nuclear grading
14. DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma
15. An analysis of two versus three grades for endometrial carcinoma
16. Economic considerations in comparing whole abdominal radiotherapy with combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: How much economic data should be collected? Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic oncology group study no. 122
17. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A gynecologic oncology group study
18. The prognostic value of nuclear versus architectural grading in endometrial adenocarcinoma: A gynecologic oncology group study